An Efficacy and Safety Study of Bortezomib Re-treatment in Multiple Myeloma
Status:
Completed
Trial end date:
2010-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety and efficacy of bortezomib in
participants with multiple myeloma who have previously responded to a bortezomib based
therapy.